Promega's Política de cookies

Empleamos cookies y tecnologías similares para mantener la funcionalidad de nuestro sitio web, analizar su rendimiento, mejorar el funcionamiento y mostrar contenido personalizado. Algunas cookies son esenciales para el buen funcionamiento de nuestro sitio web. El resto no serán instaladas en su equipo sin su consentimiento. Visite la Política de Cookies para obtener mayor detalle.

new-kit-box new-kit-box new-kit-box

Sensitive, Simple, and Homogeneous Detection of cAMP, cGAMP and cGMP

  • No Wash, Homogeneous Format: Add-and-read protocol simplifies your workflow and minimizes handling
  • Exceptional Sensitivity and Specificity: Detect low-level cyclic nucleotides with minimal cross-reactivity
  • Flexible and Scalable: Compatible with 96- and 384-well plates to meet varied screening demands
  • Rapid, Reliable Results: Obtain luminescent readings within minutes

Catalog Number:

Choose an assay

Size

Catalog Number: CS3592A05

Consultar Precio

This product is available under our Early Access program - Learn More

Catalog Number: CS3592A08

Consultar Precio

This product is available under our Early Access program - Learn More

Catalog Number: CS3592A13

Consultar Precio

This product is available under our Early Access program - Learn More

Overview
Protocols
Specifications
Resources
Related Products

Overview

Lumit® Second Messenger Assays offer robust, no-wash luminescent competitive binding methods ideal for quantifying intracellular cyclic nucleotides (cAMP, cGMP or cGAMP) directly from cell lysates. Utilizing Promega's innovative Lumit® technology based on NanoLuc® Luciferase structural complementation technology, these assays deliver sensitive detection with streamlined workflows suitable for high-throughput screening and drug discovery applications.

Assay Workflow

19644MA

The Lumit® cyclic nucleotide assays include a tracer composed of cyclic nucleotide labeled with SmBiT (Tracer), a primary mouse anti-cyclic nucleotide monoclonal antibody, and a secondary anti-mouse antibody conjugated to LgBiT. In the absence of unlabeled cyclic nucleotide, the tracer binds the antibodies to form a complex, bringing SmBiT and LgBiT into close proximity and reconstituting the Nanoluc® luciferase. Upon addition of Lumit® Detection Substrate, this interaction generates maximal luminescent signal output. When unlabeled cyclic nucleotide is present in increasing concentrations, it competes with the tracer for antibody binding, resulting in a reduction of luminescent signal proportional to the unlabeled cAMP concentration.

In the Literature

These peer-reviewed papers demonstrate how Lumit® Second Messenger Assays are used to monitor cAMP, cGAMP and cGMP from multiple cell types and biochemical reactions.

paper01

Lumit® cAMP Assay

Mikheil, D. et al. A bioluminescent and homogeneous assay for monitoring GPCR-mediated cAMP modulation and PDE activity. Sci. Rep. 14(1):4440.

paper02

Lumit® cGAMP Assay

Hsiao, K., et al. Homogeneous and bioluminescent biochemical and cellular assay for monitoring cGAMP and enzymes that generate and degrade cGAMP. Sci. Rep. 14, 31165.

paper03

Lumit® cGMP Assay

Murray, N.H. et al. A homogeneous bioluminescent system to monitor cyclic guanosine monophosphate. ACS Pharmacol. Transl. Sci. 6(12):1851–1858.

Protocols

No protocols available

Specifications

Catalog Number:

Contenido

Item Part # Presentación

2’, 3’- cGAMP Standard, 1mM

CS3592A01 1 × 10μl

Lumit® 2’, 3’-cGAMP-Tracer, 100X

CS3592A02 1 × 35μl

Anti-2’, 3’-cGAMP mAb, 100X

CS3592A03 1 × 35μl

Antibody Dilution Solution, 2X

CS3592A04 2 × 1.0ml

Digitonin

G944B 1 × 175μl

Lumit® Detection Substrate C

VB103A 2 × 200μl

Lumit® Immunoassay Buffer C, 10X

VB115A 1 × 1.5ml

Lumit® Anti-Mouse Ab-LgBiT

W102A 1 × 30μl

Certificado de Análisis

Search by lot number

Condiciones de Almacenaje

BB

Patentes y Exclusiones

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

Contenido

Item Part # Presentación

Anti-cAMP antibody (mouse)

CS3592A06 1 × 30μl

cAMP Tracer

CS3592A07 1 × 16μl

Digitonin

G944B 1 × 175μl

cAMP, 1mM

V642B 1 × 100μl

Lumit® Detection Substrate C

VB103A 2 × 200μl

Lumit® Immunoassay Buffer C, 10X

VB115A 1 × 1.5ml

Lumit® Anti-Mouse Ab-LgBiT

W102A 2 × 30μl

Certificado de Análisis

Search by lot number

Condiciones de Almacenaje

BB

Patentes y Exclusiones

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

Contenido

Item Part # Presentación

cGMP Standard, 1mM

CS3592A09 1 × 10μl

2x Neutralization Buffer

CS3592A10 2 × 750μl

cGMP-SmBiT Tracer

CS3592A11 1 × 25μl

Anti-cGMP mAb

CS3592A12 1 × 25μl

Digitonin

G944B 1 × 175μl

Lumit® Detection Substrate C

VB103A 2 × 200μl

Lumit® Immunoassay Buffer C, 10X

VB115A 2 × 1.5ml

Lumit® Anti-Rabbit Ab-LgBiT

W104A 2 × 30μl

Certificado de Análisis

Search by lot number

Condiciones de Almacenaje

BB

Patentes y Exclusiones

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.